Question · Q3 2025
Phillip J. Jungwirth asked about HF Sinclair's financing strategy for its pipeline expansion projects and the rationale behind the potential reversal of the Medicine Bow pipeline.
Answer
Steve Ledbetter, EVP of Commercial, stated that HF Sinclair has multiple financing options for the pipeline projects but is not at FID. Tim Go, CEO, noted the overall cost is expected to be significantly lower than other rumored projects. Steve Ledbetter, EVP of Commercial, explained the Medicine Bow reversal is to move Rockies barrels west due to increased Mid-Con supply into Denver, with longer-term plans to move Mid-Con barrels into PADD 5.